February 29, 2024

  * New CT 5300 system provides more accurate and reliable imaging results to
    better manage increase in complex cardiac cases where precise patient
    diagnosis is crucial
  * Philips' latest innovation leverages the power of AI at every stage in CT
    scanner operation to enhance productivity and diagnostic capabilities of
    high-throughput, short-staffed radiology departments

Amsterdam, the Netherlands and Vienna, Austria - Royal Philips
(http://www.philips.com/newscenter) (NYSE: PHG, AEX: PHIA), a global leader in
health technology, today announced the launch of Philips CT 5300
(https://philips.com.au/healthcare/resources/landing/ct-5300) system equipped
with advanced AI capabilities designed to be used for diagnosis, interventional
procedures and screening. The flexible X-ray CT system increases diagnostic
confidence, streamlines workflow efficiency, and maximizes system up-time,
helping to improve patient outcomes and department productivity. As healthcare
providers strive to deliver high-quality care to patients, at #ECR2024
(https://www.philips.co.uk/healthcare/about/events-calendar/ecr) Philips is
partnering with its customers to improve productivity and access to more
sustainable healthcare.
CT plays an important role in the diagnosis of cardiac disease. Recent research
indicates a "CT first" strategy to triage patients presenting with chest pain
with undiagnosed coronary artery disease has been shown to improve patient care
by helping them avoid more invasive procedures (1). However, a lack of
availability of high-quality CT systems, or physicians qualified to read cardiac
CT exams, often prevents this approach. The Philips CT 5300 system meets
advanced diagnostic imaging requirements for cardiac care patient guidelines, as
well as for other challenging areas such as trauma care and interventional
procedures.
The system also integrates virtual tools for real-time collaboration and
clinical/technical support, which can be instrumental in overcoming challenges
related to increased patient caseloads, complex cases, staff shortages, and
budget constraints. By bringing clinical expertise and functionality previously
associated with high-end scanners into a more affordable, versatile system,
Philips is committed to making advanced medical technology more accessible to
more patients. Emphasizing lifetime value and sustainability, the CT 5300 is
designed to lower energy consumption.
The new CT 5300 system is already installed at several European hospitals and
has been well-received. "CT 5300 offers CT imaging from head to toe, combined
with high-end functionality such as coronary angiography, delivering an
extremely broad spectrum of applications, helping us to better manage increased
volumes of patients," said Dr. Hilmar Kühl, Head of Radiology at St. Bernhard-
Hospital Kamp-Lintfort, Germany. "With this latest system from Philips, we see
an improvement in image quality with Precise Imaging, and for the first time, we
can now visualize cardiac anatomy by using Precise Cardiac nearly artifact-free,
which is very valuable to help improve cardiac care for our patients."
"We listened to radiologists about the issues they face every day and what they
wanted out of a next-generation CT system. We then combined the latest imaging
and AI technologies to meet their needs and created a system that delivers next-
level diagnostic confidence, empowers workflows, and ensures lifetime value,"
said Frans Venker, Business Leader of CT at Philips. "We've leveraged AI in
virtually every aspect of the CT 5300, freeing both CT technicians and
radiologists from tedious, time-consuming tasks so they can spend more time
focused on their patients."
Next-level diagnostic confidence and workflow efficiency
The new system introduces Nanopanel Precise, the industry's first detector built
from the ground up specifically for AI-based reconstruction. This brand-new
detector leverages the full capabilities of Philips Precise Image
(https://www.documents.philips.com/assets/20240223/4f2cbfa4d0df428f94bfb11f01751
a87.pdf) reconstruction software to deliver high-quality images at much lower
radiation dose. At 80% lower dose, Precise Image achieves up to 85% lower noise
and 60% better low-contrast detectability than conventional image reconstruction
(2). Combined with Precise Cardiac motion compensation, Precise Image makes the
CT 5300 particularly suitable for high-quality, motion-free, cardiac imaging (3)
in patients with high heart rates or heart-rate variability.
Where additional expertise or technical support is required during an exam, the
new system also features virtual tools like Philips CT Collaboration Live (4) to
facilitate remote collaboration, education, and training. More time spent with
patients means a better patient experience, while greater productivity and ease
of working enhance the operator experience to help mitigate staff shortages and
overload.
(1) Markus Scherer, MD, Atrium Health-Sanger Heart and Vascular Institute,
Charlotte, NC. The study findings were presented February 1, 2024 at the
American College of Cardiology (ACC) Cardiovascular Summit in Washington, DC.
(2) Lower image noise, improved low-contrast detectability, and/or dose
reduction were tested using reference body protocols. All metrics were tested on
phantoms. Low-contrast detectability tests were performed using 1.0 mm slices,
and tested on the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using an
auto tool "CHO" (Channelized Hotelling Observer). Data on file. Philips White
Paper 'Basic IMR testing, considerations and image quality trends'.
https://www.philips.co.uk/c-dam/b2bhc/gb/resource-
catalog/landing/brightontender/ct-imr-white-paper-lr.pdf
(3) Precise Image for cardiac scans is 510(k) pending -not available for sale in
the USA.
(4) 510(k) pending -not available for sale in the USA. Not available in all
geographies.
For further information, please contact:
Kathy O'Reilly
Philips Global External Relations
Tel.: +1 978-221-8919
E-mail: kathy.oreilly@philips.com (mailto:kathy.oreilly@philips.com)
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and well-being through meaningful
innovation. Philips' patient- and people-centric innovation leverages advanced
technology and deep clinical and consumer insights to deliver personal health
solutions for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-
guided therapy, monitoring, and enterprise informatics, as well as in personal
health. Philips generated 2023 sales of EUR 18.2 billion and employs
approximately 69,700 employees with sales and services in more than 100
countries. News about Philips can be found at www.philips.com/newscenter
(http://www.philips.com/newscenter).
Â